The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Investment with representation on the Board of Directors and technical know-how
Multiples is the first private equity (PE) investor in the company
The company also raised Rs 270 crore investment from Temasek in 2019
The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Upon closing, the Quakertown business will become an independent company called Microsize
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
Subscribe To Our Newsletter & Stay Updated
